Correlation Between Acticor Biotech and Entech SE

Can any of the company-specific risk be diversified away by investing in both Acticor Biotech and Entech SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acticor Biotech and Entech SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acticor Biotech SAS and Entech SE SAS, you can compare the effects of market volatilities on Acticor Biotech and Entech SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acticor Biotech with a short position of Entech SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acticor Biotech and Entech SE.

Diversification Opportunities for Acticor Biotech and Entech SE

-0.26

Correlation Coefficient

Acticor Biotech  Entech SE

Very good diversification

The 3 months correlation between Acticor and Entech is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Acticor Biotech SAS and Entech SE SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entech SE SAS and Acticor Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acticor Biotech SAS are associated (or correlated) with Entech SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entech SE SAS has no effect on the direction of Acticor Biotech i.e., Acticor Biotech and Entech SE go up and down completely randomly.

Pair Corralation between Acticor Biotech and Entech SE

Assuming the 90 days trading horizon Acticor Biotech SAS is expected to under-perform the Entech SE. In addition to that, Acticor Biotech is 3.06 times more volatile than Entech SE SAS. It trades about -0.01 of its total potential returns per unit of risk. Entech SE SAS is currently generating about -0.01 per unit of volatility. If you would invest  950.00  in Entech SE SAS on October 26, 2024 and sell it today you would lose (358.00) from holding Entech SE SAS or give up 37.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Acticor Biotech SAS  vs.  Entech SE SAS

Acticor Biotech SAS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acticor Biotech SAS has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Entech SE SAS

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Entech SE SAS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Entech SE is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Acticor Biotech and Entech SE

The main advantage of trading using opposite Acticor Biotech and Entech SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acticor Biotech position performs unexpectedly, Entech SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entech SE will offset losses from the drop in Entech SE's long position.

The idea behind Acticor Biotech SAS and Entech SE SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.